The human CC chemokine receptor 5 (CCR5) gene -: Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons

被引:144
|
作者
Mummidi, S
Ahuja, SS
McDaniel, BL
Ahuja, SK
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis, San Antonio, TX 78284 USA
[2] S Texas Vet Hlth Care Syst, Audie L Murphy Div, San Antonio, TX 78284 USA
关键词
D O I
10.1074/jbc.272.49.30662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human CC chemokine receptor 5 (CCR5), mediates the activation of cells by the chemokines macrophage inflammatory protein-la; macrophage inflammatory protein-1 beta, and RANTES, and serves as a fusion cofactor for macrophage-tropic strains of human immunodeficiency virus type 1. To understand the molecular mechanisms that regulate human CCR5 gene expression, we initiated studies to determine its genomic and mRNA organization, Previous studies have identified a single CCR5 mRNA isoform whose open reading frame is intronless, We now report the following novel findings, 1) Complex alternative splicing and multiple transcription start sites give rise to several distinct CCR5 transcripts that differ in their 5'-untranslated regions (UTR), 2) The gene is organized into four exons and two introns, Exons 2 and 3 are not interrupted by an intron, Exon 4 and portions of exon 3 are shared by all isoforms, Exon 4 contains the open reading frame, 11 nucleotides of the 5'-UTR and the complete 3'-UTR. 3) The transcripts appear to be initiated from two distinct promoters: an upstream promoter (P-U), upstream of exon 1, and a downstream promoter (P-D), that includes the "intronic" region between exons 1 and 3, 4) P-U and P-D lacked the canonical TATA or CAAT motifs, and are AT-rich, 5) P-D demonstrated strong constitutive promoter activity, whereas P-U was a weak promoter in all three leukocyte cell environments tested (THP-1, Jurkat, and K562), 6) We provide evidence for polymorphisms in the noncoding sequences, including the regulatory regions and 5'-UTRs, The structure of CCR5 was strikingly reminiscent of the overall structure of other chemokine/chemoattractant receptors, underscoring an important evolutionarily conserved function for a prototypical gene structure. This is the first description of functional pro meters for any CC chemokine receptor gene, and we speculate that the complex pattern of splicing events and dual promoter usage may function as a versatile mechanism to create diversity and flexibility in the regulation of CCR5 expression.
引用
收藏
页码:30662 / 30671
页数:10
相关论文
共 37 条
  • [21] The homozygous D32 deletion of the CC chemokine receptor CCR5 gene protects against rheumatoid arthritis.
    Pablos, JL
    Carreira, PE
    Serrano, L
    Santiago, B
    Balsa, A
    Vicario, JL
    GomezReino, JJ
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 756 - 756
  • [22] Rapid determination of the Δ32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by LightCycler real-time polymerase chain reaction
    Nischalke, HD
    Nattermann, J
    Lichterfeld, M
    Woitas, RP
    Rockstroh, JK
    Sauerbruch, T
    Spengler, U
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (07) : 750 - 754
  • [23] Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression
    Tang, J
    Rivers, C
    Karita, E
    Costello, C
    Allen, S
    Fultz, PN
    Schoenbaum, EE
    Kaslow, RA
    GENES AND IMMUNITY, 1999, 1 (01) : 20 - 27
  • [24] Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression
    J Tang
    C Rivers
    E Karita
    C Costello
    S Allen
    PN Fultz
    EE Schoenbaum
    RA Kaslow
    Genes & Immunity, 1999, 1 : 20 - 27
  • [25] Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression
    Esposito, S
    Zehender, G
    Zuccotti, GV
    Vegni, C
    Galli, L
    Vecchi, V
    Agostoni, C
    Rancilio, L
    De Maddalena, C
    Clerici, M
    Principi, N
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (09) : 847 - 849
  • [26] The effect of chemokine receptor gene polymorphisms (CCR2V64I, CCR5-59029G>A and CCR5Δ32) on renal allograft survival in Pakistani transplant patients
    Firasat, Sadaf
    Raza, Ali
    Abid, Aiysha
    Aziz, Tahir
    Mubarak, Mohammad
    Naqvi, Syed Ali Anwar
    Rizvi, Syed Adeebul Hasan
    Mehdi, Syed Qasim
    Khaliq, Shagufta
    GENE, 2012, 511 (02) : 314 - 319
  • [27] STRUCTURE OF THE HUMAN LUTEINIZING-HORMONE CHORIOGONADOTROPIN RECEPTOR GENE - UNUSUAL PROMOTER AND 5'-NONCODING-REGIONS
    ATGER, M
    MISRAHI, M
    SAR, S
    LEFLEM, L
    DESSEN, P
    MILGROM, E
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1995, 111 (02) : 113 - 123
  • [28] Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine
    M J Arranz
    J Munro
    M J Owen
    G Spurlock
    P C Sham
    J Zhao
    G Kirov
    D A Collier
    R W Kerwin
    Molecular Psychiatry, 1998, 3 : 61 - 66
  • [29] Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine
    Arranz, MJ
    Munro, J
    Owen, MJ
    Spurlock, G
    Sham, PC
    Zhao, J
    Kirov, G
    Collier, DA
    Kerwin, RW
    MOLECULAR PSYCHIATRY, 1998, 3 (01) : 61 - 66
  • [30] Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1 beta, and MIP-1 alpha
    Raport, CJ
    Gosling, J
    Schweickart, VL
    Gray, PW
    Charo, IF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (29) : 17161 - 17166